A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether vacuumassisted closure therapy (VAC) is superior to conventional therapy for treating post-sternotomy mediastinitis. Altogether >261 papers were found using the reported search, of which 9 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Several studies indicate that VAC therapy is associated with shorter lengths of intensive care and in-hospital stay as well as faster rates of wound healing and fewer dressing changes. It has also been shown that VAC therapy is correlated with a statistically significant reduction in reinfection rates, particularly those that occur in the early postoperative period (at the 1-week follow-up). Patients can be discharged with the dressing in situ and managed in the community with a view to delayed closure or reconstruction. However, the studies comparing VAC with conventional therapy are all retrospective in nature and reinforce the need for randomized controlled trials in order to more accurately establish differences in outcomes between VAC and conventional therapy. Additionally, owing tło the variability of treatment protocols within the non-VAC arm, it is more challenging to draw definitive conclusions regarding the superiority of VAC therapy to every modality that is considered conventional treatment. We conclude that VAC therapy is a portable and an increasingly economical option for the treatment of post sternotomy mediastinitis. Although reductions in mortality rates were not reproduced in all studies, evidence suggests that VAC should still be considered as a first-line therapy for post-sternotomy mediastinitis and as a bridge therapy to musculocutaneous reconstruction or primary closure.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
CLINICAL SCENARIO
You are currently attached to two consultants, each with a patient with culture-positive mediastinitis following coronary artery bypass grafting (CABG). You are asked by one of them to carry out surgical debridement, closed irrigation and reconstruction. However, the other consultant asks you to use vacuum-assisted closure therapy (VAC) therapy and delayed closure, as he believes it is superior to conventional therapy (CvT) . You wonder what the evidence is for this statement and decide to carry out a literature search. This study showed that NPWT is associated with a significantly lower rate of early reinfections (persistent, Centres for Disease Control and Prevention (CDC) defined DSWI after at least one adequate treatment attempt) that required surgical revision as well as a trend towards lower 1-year mortality rates and fewer late chronic infections (infections diagnosed after discharge requiring surgical intervention that did not fulfill the CDC criteria for DSWI)
THREE-PART QUESTION
The authors conclude that NPWT led to fewer surgical reinterventions and should be used as first-line therapy in most DWSI patients Limitations: the groups were both small and therapy was conducted over different time periods
In-hospital mortality
CvT: 1 (4%) NPWT: 0 (0%) P = 1
1-year mortality
CvT: 4 (17%) NPPWT: 0 (0%) P = 0.07
Early reinfection
CvT: 8 (35%) NPWT: 1 (5%) P = 0.02
Chronic infection
CvT: 4 (17%) NPPWT: (0%) P = 0.07 [3] also found no difference in mortality, but did find a reduction in length of hospital stay (P < 0.05) in their patients treated with VAC therapy compared with those treated with closed irrigation in addition to granulated sugar and hyperbaric therapy (n = 200). They also found that the rate of reduction in C-reactive protein was significantly faster in the VAC group (P < 0.05).
Continued
Steingrimsson et al. [4] showed that VAC therapy significantly reduced the early post-treatment recurrence of mediastinitis when compared with open packing and closed irrigation (n = 43). However, they found no significant differences in length of stay, early or late mortality rates. The authors believe that VAC led to lower rates of chronic infections and necessitated fewer surgical reinterventions. Vos et al. [5] compared patients (n = 113) who underwent open packing with those on VAC therapy and found that CvT was associated with a prolonged intensive care stay (P = 0.0081) and increased rates of early in-hospital mortality (P < 0.05). VAC therapy increased patient comfort and allowed for discharge and outpatient review while the dressing was still in situ. However, despite the use of polyvinyl alcohol dressing as protection there was still one incident of right ventricular rupture secondary to the high negative pressure (−125 mmHg) produced by the VAC system.
De Feo et al [6] studied 157 patients with post-sternotomy mediastinitis who had undergone VAC therapy after debridement or conventional treatment, which consisted of primary wound reopening, debridement, closed chest irrigation, topical application of granulated sugar and pectoralis musculocutaneous reconstruction. They found lower re-infection rates (P < 0.05) and shorter hospital stays (P < 0.05) but no significant differences in mortality rates.
Assmann et al [7] compared VAC therapy with primary rewiring and disinfectant irrigation and showed that rewiring was associated with a greater chance of treatment failure and led to a poorer outcome (n = 192). Despite having worse baseline characteristics, the VAC group had shorter lengths of intensive care unit and hospital stay (P < 0.05) and increased survival (P < 0.05), with lower rates of postoperative complications. This improvement in survival in the VAC group was found despite more frequent use of both internal thoracic arteries, which is normally associated with poorer outcomes.
Petzina et al. [8] also found a reduced mortality rate (P < 0.05), lower sternal reinfection rate (P = 0.008) as well as a tendency towards shorter lengths of hospital stay (P = 0.08) when comparing the VAC group with conventionally treated patients who had drainage and irrigation, omentoplasty (when appropriate) and stabilization of the sternum (n = 118). They postulated that the increased number of operative procedures required for the VAC treatment (mean 5.5) compared with the CvT (mean 1) offered optimal infection control due to repeated debridement and microbiological testing.
De Feo et al. [9] , looked specifically at methicillin-resistant poststernotomy mediastinitis (n = 69). They found that closed irrigation, and when necessary granulated sugar or musculocutaneous reconstruction, resulted in a longer hospital stay (P < 0.05), increased rates of reinfection and longer healing times (P < 0.05) than those treated with VAC therapy. Despite the small sample size, the authors showed a significant decrease in the time necessary for wound healing when VAC was used.
Segers et al. [10] also reported lower rates of recurring infection and therapeutic failure in their patients who had undergone VAC therapy compared with those who had closed drainage (P < 0.05) (n = 63). The small sample size and retrospective nature of the study encourage a careful interpretation of those results.
CLINICAL BOTTOM LINE
VAC therapy is a portable and an increasingly economical option for the treatment of post-sternotomy mediastinitis. VAC therapy removes wound exudate, oedema and cell debris and has been shown to increase the rate of granulation and wound healing [12] . This results in fewer dressing changes and improved patient comfort. Patients with VAC dressings may be managed in the community with a view to delayed closure or later reconstruction. Several studies indicate that VAC therapy is associated with shorter lengths of intensive care and in-hospital stay as well as faster rates of wound healing. Studies also show a statistically significant reduction in reinfection rates, particularly those that occur in the early postoperative period (at the 1-week follow-up). However, the studies comparing VAC with CvT were all retrospective in nature. The great variability in what the CvT was in the non-VAC arms of the studies must be taken into account when considering the evidence combined. This reinforces the need for randomized controlled trials in order to more accurately establish differences in outcomes between VAC and CvT. Although reductions in mortality rates were not reproduced in all studies, evidence suggests that VAC should still be considered as a first-line therapy for poststernotomy mediastinitis and as a bridge therapy to reconstruction or primary closure.
